Ascidian Therapeutics logo

Ascidian Therapeutics

Rewriting RNA

48 employees · est. 2020 · Boston, United States

VS
Wave Life Sciences logo

Wave Life Sciences

Unlocking the broad potential of RNA medicines to transform human health

379 employees · est. 2012 · Cambridge, United States

Wave Life Sciences is the older company (2020 vs 2012); Wave Life Sciences is the larger of the two.

Side-by-Side Comparison

Ascidian Therapeutics Wave Life Sciences
Founded
2020 2012 older
Headquarters
Boston, United States Cambridge, United States
Employees
48 379 larger
Industry
Biotechnology, Health and Wellness Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Post Ipo Equity
Total Funding
$90.00M Not tracked yet
Funding Rounds
3 10
Services
RNA exon editing platform, Developing RNA-based medicines, Manufacturing partnership for RNA therapies Not tracked yet
Target Customers
Patients with genetic diseases, Healthcare professionals, Biotechnology researchers Not tracked yet
Taxonomy
RNA Therapeutics, Gene Editing, Post-transcriptional Editing, Ophthalmology, Neurological Disorders, Neuromuscular Disorders, Rare Diseases, Functional Proteins, Exon Editing, Disease Treatment, Precision Medicine, Preclinical Programs, Therapeutic Innovation Genetic Medicines, RNA Editing, RNA Interference, Oligonucleotides, Drug Development, Therapeutic Modalities, Rare Disorders, Precision Medicine, Clinical Stage, Disease Biology, Human Genetics, Life-changing Treatments, Precision Design, Stereopure Oligonucleotides
Website
ascidian-tx.com wavelifesciences.com
Ascidian Therapeutics logo

About Ascidian Therapeutics

Ascidian Therapeutics, founded in 2020, is a pioneering company in the Biotechnology and Health and Wellness industries, headquartered in the United States. Their slogan, "Rewriting RNA," encapsulates their innovative approach to disease treatment by focusing on RNA editing. By targeting exons at th...

Wave Life Sciences logo

About Wave Life Sciences

Wave Life Sciences is a biotechnology company with a powerful vision to transform human health by unlocking the broad potential of RNA medicines. The company's RNA medicines platform, PRISM, integrates various modalities, chemistry innovation, and deep insights into human genetics to bring about sci...

We will tell you when either one moves

BounceWatch watches Ascidian Therapeutics and Wave Life Sciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Ascidian Therapeutics and Wave Life Sciences — by email.

Frequently Asked Questions

Ascidian Therapeutics — Rewriting RNA. Wave Life Sciences — Unlocking the broad potential of RNA medicines to transform human health. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Ascidian Therapeutics has raised $90.00M while Wave Life Sciences has raised undisclosed funding.
Ascidian Therapeutics and Wave Life Sciences operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Ascidian Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Ascidian Therapeutics on 9 Jun 2026, and Wave Life Sciences on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy